Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DELTA: Cyclosporine A (C-2h) vs Tacrolimus in Liver Transplant
NCT00149994Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2002
- Primary completion
- Dec 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cyclosporine in liver transplantation, sponsored by Novartis. Primary endpoint: Biopsy Proven Acute Rejection at 3 months. Started Dec 2002; status: completed.
02
Drugs
cyclosporine
03
Conditions
liver transplantation
Beyond the preview
Go deeper on NCT00149994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00149994.